News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Many Non-Antibiotic Drugs Affect Gut Bacteria
Catherine Offord | Mar 20, 2018
A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.
High-Fiber Diet Shifts Gut Microbes, Lowering Blood Sugar in Diabetics
Ashley Yeager | Mar 9, 2018
New findings suggest that promoting the growth of fiber-loving bacteria may help manage type 2 diabetes.
How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
Diana Kwon | Jan 10, 2018
Scientists are beginning to unravel the ways in which we develop a healthy relationship with the bugs in our bodies.
In-Depth Look at the Human Microbiome
Jef Akst | Sep 20, 2017
Hundreds of samples from microbes living in the gut, skin, mouth, and vagina add to the human microbiome “fingerprint.”
Ruth Williams | Jul 17, 2017
Two research teams develop tools for tinkering with a bacterial genus prominent in human guts.
Messing with the Microbiome
Ruth Williams | Jul 16, 2017
Two new techniques allow researchers to manipulate the activity of gut bacteria.
Behavioral Changes in Mice Given Antibiotics in Early Life
Jef Akst | Apr 10, 2017
Mice exposed to low doses of penicillin in utero or as young pups exhibited long-term behavioral differences not seen in their non-exposed counterparts, according to a study.
In Certain Social Bees, Gut Microbiomes Follow Phylogeny
Ashley P. Taylor | Mar 29, 2017
Corbiculate bees and their gut-dwelling microbes have been coevolving since the social species evolved from their solitary ancestors around 80 million years ago, scientists suggest.
Antibiotic Therapy During Infancy Increases Type 1 Diabetes Risk in Mice
Alison F. Takemura | Aug 22, 2016
Three therapeutic doses administered during early life disturb the animals’ microbiomes and lead to enduring changes in the immune systems of non-obese diabetic mice, researchers report.
Fecal Transplant Pill Fails Trial
Jef Akst | Aug 1, 2016
Seres Therapeutics’s microbiome-targeting therapy for recurrent
infection fails a Phase 2 clinical trial.